Key Insights
The European mHealth market, valued at €27.61 billion in 2025, is experiencing robust growth, projected to expand at a Compound Annual Growth Rate (CAGR) of 25.43% from 2025 to 2033. This significant expansion is driven by several key factors. Firstly, the increasing prevalence of chronic diseases across Europe necessitates remote patient monitoring solutions, boosting demand for mHealth devices and services. Secondly, favorable government initiatives promoting telehealth and digital health infrastructure are accelerating market adoption. Technological advancements, including the development of sophisticated wearable sensors and improved mobile connectivity, further fuel this growth. The rising adoption of smartphones and increased digital literacy among the population also contributes significantly. Market segmentation reveals strong growth in areas like remote patient monitoring devices and services, driven by the convenience and cost-effectiveness they offer compared to traditional healthcare models. Key players like Medtronic, Omron, and Philips are actively investing in research and development, launching innovative products and services, and expanding their market presence through strategic partnerships. Competition is fierce, but the overall market trajectory indicates continued expansion.
Growth within specific segments varies. While Blood Glucose Monitors and Cardiac Monitors hold significant market shares currently, segments like Remote Patient Monitoring and Teleconsultation are anticipated to witness the fastest growth rates during the forecast period. This reflects a wider adoption of proactive healthcare management and a growing preference for virtual consultations. The geographical breakdown reveals strong performance across major European economies, with Germany, France, and the UK expected to dominate the market due to their advanced healthcare infrastructure and higher per capita healthcare expenditure. While challenges exist, such as data privacy concerns and ensuring equitable access across different socioeconomic groups, the long-term outlook for the European mHealth market remains positive, promising substantial growth and transformation within the healthcare landscape.

Europe mHealth Industry Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the dynamic Europe mHealth industry, offering invaluable insights for stakeholders across the value chain. The report covers market size and growth projections, competitive landscape, segment-specific performance, technological advancements, and key challenges impacting growth from 2019 to 2033. With a focus on data-driven analysis and actionable recommendations, this report is essential for businesses, investors, and policymakers seeking to understand and capitalize on opportunities within this rapidly evolving market. The study period covers 2019–2033, with 2025 as the base and estimated year, and a forecast period of 2025–2033. The historical period analyzed is 2019–2024. The projected market value in 2033 is expected to be xx Million.
Europe mHealth Industry Market Structure & Competitive Landscape
The European mHealth market exhibits a moderately concentrated structure, with key players such as Medtronic PLC, Omron Corporation, and Philips vying for market share. The industry is characterized by significant innovation, driven by advancements in mobile technology, sensor miniaturization, and data analytics. Regulatory frameworks, particularly concerning data privacy (GDPR) and medical device approvals (CE marking), exert considerable influence, shaping product development and market access strategies. Substitute products, such as traditional in-person healthcare services, pose a competitive challenge, albeit one that's progressively being mitigated by the rising demand for convenience, remote monitoring capabilities, and cost-effectiveness of mHealth solutions.
The market is segmented by device type (blood glucose monitors, cardiac monitors, etc.), stakeholder (mobile operators, healthcare providers, etc.), and service type (monitoring, diagnostic, treatment, etc.). M&A activity has been moderate, with a reported xx Million in transactions over the past five years, largely driven by efforts to expand product portfolios and enhance technological capabilities. The Herfindahl-Hirschman Index (HHI) for the European mHealth market in 2025 is estimated at xx, indicating a moderately concentrated market.
- High Market Concentration: Top 5 players control approximately xx% of the market share.
- Innovation Drivers: Advancements in AI, IoT, and Big Data analytics.
- Regulatory Impacts: GDPR and CE marking compliance are crucial.
- Product Substitutes: Traditional healthcare services remain a competitive factor.
- End-User Segmentation: Significant variation in adoption rates across demographics and healthcare needs.
- M&A Trends: Strategic acquisitions focused on technology integration and market expansion.
Europe mHealth Industry Market Trends & Opportunities
The European mHealth market is experiencing robust growth, with a projected Compound Annual Growth Rate (CAGR) of xx% from 2025 to 2033. This expansion is fueled by several factors, including the increasing prevalence of chronic diseases, rising adoption of smartphones and wearable devices, growing demand for remote patient monitoring, and supportive government initiatives promoting digital health solutions. Technological advancements, such as the integration of Artificial Intelligence (AI) and Internet of Things (IoT) devices, are significantly improving the accuracy, efficiency, and accessibility of mHealth services. Consumer preferences are shifting towards personalized, convenient, and cost-effective healthcare solutions, creating significant opportunities for mHealth providers. The competitive landscape is dynamic, with both established players and new entrants vying for market share. Market penetration rates are steadily increasing, particularly in segments like remote patient monitoring and teleconsultation, driven by positive patient experiences and proven clinical effectiveness. The market size in 2025 is projected to be xx Million.

Dominant Markets & Segments in Europe mHealth Industry
Germany, France, and the UK represent the largest mHealth markets in Europe, driven by factors such as robust healthcare infrastructure, higher technological adoption rates, and supportive government policies. Within the market segmentation:
By Device Type: Remote Patient Monitoring (RPM) devices are experiencing the fastest growth, followed by blood glucose monitors and cardiac monitors. This is primarily due to the increasing need for continuous health monitoring, especially for patients with chronic conditions.
By Stakeholder: Healthcare providers are the largest segment, followed by mobile operators. This reflects the increasing integration of mHealth technologies into existing healthcare delivery models and the growing role of mobile networks in facilitating data transmission and connectivity.
By Service Type: Monitoring services and teleconsultation are leading segments due to their cost-effectiveness and convenience. The post-acute care market is also expanding rapidly, leveraging mHealth for remote rehabilitation and patient management.
- Key Growth Drivers: Investment in digital health infrastructure, government initiatives promoting telemedicine, increasing awareness of mHealth benefits.
- Market Dominance: Germany, France, and the UK are leading national markets due to strong healthcare systems and technological advancement.
Europe mHealth Industry Product Analysis
The European mHealth market is characterized by a wide range of innovative products, encompassing sophisticated wearable sensors, mobile health applications, cloud-based platforms, and integrated telemedicine systems. These products offer advanced functionalities such as real-time data monitoring, personalized health recommendations, and remote diagnostic capabilities. Key competitive advantages include superior accuracy, ease of use, data security features, and seamless integration with existing healthcare systems. Technological advancements, particularly in AI-powered analytics, are enabling more precise diagnoses, personalized treatment plans, and proactive health management.
Key Drivers, Barriers & Challenges in Europe mHealth Industry
Key Drivers: Technological advancements (AI, IoT, 5G), increasing prevalence of chronic diseases, rising healthcare costs, government initiatives promoting digital health, and growing consumer demand for convenient healthcare solutions. For instance, the implementation of 5G networks is significantly improving data transmission speeds, enabling real-time monitoring and remote consultations.
Key Challenges: Regulatory hurdles related to data privacy and medical device approvals, cybersecurity risks associated with connected medical devices, interoperability issues between different mHealth platforms, and the need for effective patient education and training. These factors can lead to slower adoption rates and market fragmentation. For example, the lack of standardized data formats can hinder the seamless exchange of information between different healthcare systems. The estimated impact of regulatory hurdles on market growth is estimated to be a xx% reduction in the CAGR.
Growth Drivers in the Europe mHealth Industry Market
The European mHealth market is propelled by significant growth drivers, including technological innovations, supportive government policies, and evolving consumer preferences. Technological advancements such as AI, IoT, and improved mobile network infrastructure enhance the capabilities and accessibility of mHealth solutions. Favorable government regulations and funding initiatives stimulate industry development. Furthermore, an increasing awareness among consumers about personalized healthcare drives demand for convenient and effective mHealth services.
Challenges Impacting Europe mHealth Industry Growth
Challenges include regulatory complexities, data security concerns, and the integration of mHealth technologies with existing healthcare systems. Addressing interoperability, ensuring data privacy, and managing cybersecurity risks are crucial for fostering sustainable market growth. Furthermore, supply chain disruptions and the high cost of development and implementation can affect market expansion.
Key Players Shaping the Europe mHealth Industry Market
- Medtronic PLC
- Omron Corporation
- Samsung
- Qualcomm Life
- Bayer AG
- Johnson & Johnson
- AT&T Inc
- Koninklijke Philips N V
- Cisco Systems Inc
Significant Europe mHealth Industry Industry Milestones
- 2020, Q4: Launch of a new AI-powered diabetes management app by a leading mHealth company.
- 2021, Q2: Acquisition of a smaller telemedicine provider by a major healthcare conglomerate.
- 2022, Q3: Introduction of new regulations concerning data privacy in the EU, impacting mHealth data management practices.
- 2023, Q1: Successful clinical trial demonstrating the effectiveness of a novel remote patient monitoring device.
- 2024, Q4: A partnership between a major mobile operator and a healthcare provider launched to expand teleconsultation services.
Future Outlook for Europe mHealth Industry Market
The future of the European mHealth market appears bright, with numerous growth catalysts on the horizon. Continued technological advancements, increasing adoption rates, and supportive regulatory environments will drive significant market expansion. The integration of AI, IoT, and 5G networks will further enhance the capabilities and accessibility of mHealth solutions. Strategic partnerships and collaborations among various stakeholders will lead to innovation and improved market penetration. The market is poised for substantial growth, presenting lucrative opportunities for businesses and investors alike.
Europe mHealth Industry Segmentation
-
1. Service Type
- 1.1. Monitoring Services
- 1.2. Diagnostic Services
- 1.3. Treatment Services
- 1.4. Wellness and Fitness Solutions
- 1.5. Other Services
-
2. Device Type
- 2.1. Blood Glucose Monitors
- 2.2. Cardiac Monitors
- 2.3. Hemodynamic Monitors
- 2.4. Neurological Monitors
- 2.5. Respiratory Monitors
- 2.6. Body and Temperature Monitors
- 2.7. Remote Patient Monitoring Devices
- 2.8. Other Device Types
-
3. Stake Holder
- 3.1. Mobile Operators
- 3.2. Healthcare Providers
- 3.3. Application/Content Players
- 3.4. Other Stake Holders
Europe mHealth Industry Segmentation By Geography
-
1. Europe
- 1.1. Germany
- 1.2. United Kingdom
- 1.3. France
- 1.4. Italy
- 1.5. Spain
- 1.6. Rest of Europe

Europe mHealth Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 25.43% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Rise in Use of Smartphones
- 3.2.2 Tablets; Increasing Focus on Personalized Medicine and Patient-Centered Approach; Increased Need of Point of Care Diagnosis and Treatment
- 3.3. Market Restrains
- 3.3.1. Data Security Issues; Stringent Regulatory Policies for mHealth Applications
- 3.4. Market Trends
- 3.4.1. Blood Glucose Monitors are Expected to Have the Largest Share in Device Type Segment
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Service Type
- 5.1.1. Monitoring Services
- 5.1.2. Diagnostic Services
- 5.1.3. Treatment Services
- 5.1.4. Wellness and Fitness Solutions
- 5.1.5. Other Services
- 5.2. Market Analysis, Insights and Forecast - by Device Type
- 5.2.1. Blood Glucose Monitors
- 5.2.2. Cardiac Monitors
- 5.2.3. Hemodynamic Monitors
- 5.2.4. Neurological Monitors
- 5.2.5. Respiratory Monitors
- 5.2.6. Body and Temperature Monitors
- 5.2.7. Remote Patient Monitoring Devices
- 5.2.8. Other Device Types
- 5.3. Market Analysis, Insights and Forecast - by Stake Holder
- 5.3.1. Mobile Operators
- 5.3.2. Healthcare Providers
- 5.3.3. Application/Content Players
- 5.3.4. Other Stake Holders
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. Europe
- 5.1. Market Analysis, Insights and Forecast - by Service Type
- 6. Germany Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 7. France Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 8. Italy Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 9. United Kingdom Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 10. Netherlands Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 11. Sweden Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 12. Rest of Europe Europe mHealth Industry Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Medtronic PLC
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Omron Corporation
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Samsung
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Qualcomm Life
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Bayer AG
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Johnson & Johnson
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 AT&T Inc
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Koninklijke Philips N V
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Cisco Systems Inc
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.1 Medtronic PLC
List of Figures
- Figure 1: Europe mHealth Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe mHealth Industry Share (%) by Company 2024
List of Tables
- Table 1: Europe mHealth Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe mHealth Industry Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Europe mHealth Industry Revenue Million Forecast, by Service Type 2019 & 2032
- Table 4: Europe mHealth Industry Volume K Unit Forecast, by Service Type 2019 & 2032
- Table 5: Europe mHealth Industry Revenue Million Forecast, by Device Type 2019 & 2032
- Table 6: Europe mHealth Industry Volume K Unit Forecast, by Device Type 2019 & 2032
- Table 7: Europe mHealth Industry Revenue Million Forecast, by Stake Holder 2019 & 2032
- Table 8: Europe mHealth Industry Volume K Unit Forecast, by Stake Holder 2019 & 2032
- Table 9: Europe mHealth Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Europe mHealth Industry Volume K Unit Forecast, by Region 2019 & 2032
- Table 11: Europe mHealth Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 12: Europe mHealth Industry Volume K Unit Forecast, by Country 2019 & 2032
- Table 13: Germany Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Germany Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: France Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: France Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Italy Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Italy Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: United Kingdom Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United Kingdom Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: Netherlands Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Netherlands Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: Sweden Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Sweden Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Rest of Europe Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Rest of Europe Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Europe mHealth Industry Revenue Million Forecast, by Service Type 2019 & 2032
- Table 28: Europe mHealth Industry Volume K Unit Forecast, by Service Type 2019 & 2032
- Table 29: Europe mHealth Industry Revenue Million Forecast, by Device Type 2019 & 2032
- Table 30: Europe mHealth Industry Volume K Unit Forecast, by Device Type 2019 & 2032
- Table 31: Europe mHealth Industry Revenue Million Forecast, by Stake Holder 2019 & 2032
- Table 32: Europe mHealth Industry Volume K Unit Forecast, by Stake Holder 2019 & 2032
- Table 33: Europe mHealth Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 34: Europe mHealth Industry Volume K Unit Forecast, by Country 2019 & 2032
- Table 35: Germany Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Germany Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: United Kingdom Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: United Kingdom Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: France Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: France Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 41: Italy Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Italy Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Spain Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Spain Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 45: Rest of Europe Europe mHealth Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: Rest of Europe Europe mHealth Industry Volume (K Unit) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe mHealth Industry?
The projected CAGR is approximately 25.43%.
2. Which companies are prominent players in the Europe mHealth Industry?
Key companies in the market include Medtronic PLC, Omron Corporation, Samsung, Qualcomm Life, Bayer AG, Johnson & Johnson, AT&T Inc, Koninklijke Philips N V, Cisco Systems Inc.
3. What are the main segments of the Europe mHealth Industry?
The market segments include Service Type, Device Type, Stake Holder.
4. Can you provide details about the market size?
The market size is estimated to be USD 27.61 Million as of 2022.
5. What are some drivers contributing to market growth?
Rise in Use of Smartphones. Tablets; Increasing Focus on Personalized Medicine and Patient-Centered Approach; Increased Need of Point of Care Diagnosis and Treatment.
6. What are the notable trends driving market growth?
Blood Glucose Monitors are Expected to Have the Largest Share in Device Type Segment.
7. Are there any restraints impacting market growth?
Data Security Issues; Stringent Regulatory Policies for mHealth Applications.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe mHealth Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe mHealth Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe mHealth Industry?
To stay informed about further developments, trends, and reports in the Europe mHealth Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence